Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01052662 · ClinicalTrials.gov registry record · Phase 2

Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults

A Phase 2 study of Opioid Dependence, sponsored by University of Massachusetts, Worcester.

Completed
Registry status
Phase 2
Development phase
87
Enrollment target
1
Study location

NCT01052662 is a Phase 2 study of Opioid Dependence that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 87 participants, below the 155-participant average among 29 other Opioid Dependence trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01052662, a Phase 2 study of Opioid Dependence, has completed, sponsored by University of Massachusetts, Worcester.

COMPLETED
Registry status
Phase 2
Development phase
87 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the effect of memantine and buprenorphine on opioid abusing behavior, to determine the effect of memantine and buprenorphine on early relapse and to evaluate the tolerability of memantine co-administrated with buprenorphine. The study seeks to determine if combined treatment of memantine and buprenorphine may provide shorter-term treatment for opioid dependence.

Conditions Studied

Opioid Dependence

Interventions

  • DRUG Placebo
  • DRUG Memantine

Study Locations (1)

Massachusetts

  • University of Massachusetts Medical School - Worcester

Trial Details

FieldValue
Enrollment Target 87 participants
Start Date 2009-10
Est. Completion 2013-10
Phase Phase 2

Sponsor

University of Massachusetts, Worcester

240 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01052662

The ClinicalTrials.gov registry entry for NCT01052662 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 155-participant average among 29 other Opioid Dependence trials with a reported enrollment target (44% lower). The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Dependence appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01052662 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01052662 about?

NCT01052662 is a clinical study titled "Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults". The purpose of this study is to examine the effect of memantine and buprenorphine on opioid abusing behavior, to determine the effect of memantine and buprenorphine on early relapse and to evaluate the tolerability of memantine co-administrated with buprenorphine. The study seeks to determine if com...

What is the current status of trial NCT01052662?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 87 participants. The study started on 2009-10. Estimated completion is 2013-10.

What conditions does trial NCT01052662 study?

This clinical trial studies the following conditions: Opioid Dependence.

What interventions are being tested in trial NCT01052662?

The interventions under investigation include: Placebo (DRUG), Memantine (DRUG).

Who is sponsoring clinical trial NCT01052662?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01052662 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Opioid Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Opioid Dependence

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.